- Home
- PSNYW vs CDXS Comparison
PSNYW vs CDXS Comparison
Compare PSNYW & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNYW
- CDXS
- Stock Information
- Founded
- PSNYW 2017
- CDXS 2002
- Country
- PSNYW Sweden
- CDXS United States
- Employees
- PSNYW 2515
- CDXS N/A
- Industry
- PSNYW Auto Manufacturing
- CDXS Major Chemicals
- Sector
- PSNYW Consumer Discretionary
- CDXS Industrials
- Exchange
- PSNYW Nasdaq
- CDXS Nasdaq
- Market Cap
- PSNYW 400.8M
- CDXS 361.3M
- IPO Year
- PSNYW N/A
- CDXS 2010
- Fundamental
- Price
- PSNYW $0.19
- CDXS $2.76
- Analyst Decision
- PSNYW
- CDXS Buy
- Analyst Count
- PSNYW 0
- CDXS 2
- Target Price
- PSNYW N/A
- CDXS $11.00
- AVG Volume (30 Days)
- PSNYW 79.7K
- CDXS 924.9K
- Earning Date
- PSNYW 03-06-2025
- CDXS 05-01-2025
- Dividend Yield
- PSNYW N/A
- CDXS N/A
- EPS Growth
- PSNYW N/A
- CDXS N/A
- EPS
- PSNYW N/A
- CDXS N/A
- Revenue
- PSNYW $2,046,740,000.00
- CDXS $59,345,000.00
- Revenue This Year
- PSNYW N/A
- CDXS $14.56
- Revenue Next Year
- PSNYW $77.28
- CDXS $21.41
- P/E Ratio
- PSNYW N/A
- CDXS N/A
- Revenue Growth
- PSNYW N/A
- CDXS N/A
- 52 Week Low
- PSNYW $0.09
- CDXS $2.47
- 52 Week High
- PSNYW $0.61
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- PSNYW 46.99
- CDXS 27.82
- Support Level
- PSNYW $0.18
- CDXS $2.56
- Resistance Level
- PSNYW $0.22
- CDXS $2.85
- Average True Range (ATR)
- PSNYW 0.02
- CDXS 0.30
- MACD
- PSNYW -0.00
- CDXS -0.09
- Stochastic Oscillator
- PSNYW 28.29
- CDXS 14.57
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.